EMN
EMN
Eastman Chemical CompanyIncome Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $1.97B ▼ | $217M ▼ | $105M ▲ | 5.32% ▲ | $0.92 ▲ | $195M ▼ |
| Q3-2025 | $2.2B ▼ | $223M ▲ | $47M ▼ | 2.13% ▼ | $0.41 ▼ | $319M ▼ |
| Q2-2025 | $2.29B ▼ | $222M ▼ | $140M ▼ | 6.12% ▼ | $1.22 ▼ | $352M ▼ |
| Q1-2025 | $2.29B ▲ | $249M ▲ | $182M ▼ | 7.95% ▼ | $1.58 ▼ | $432M ▼ |
| Q4-2024 | $2.25B | $176M | $330M | 14.7% | $2.85 | $482M |
What's going well?
Net income and EPS jumped this quarter, mainly due to a big tax benefit. R&D spending is steady, and the company remains profitable at the core level.
What's concerning?
Revenue and gross profit both fell sharply, and operating margins are getting squeezed. The improvement in net income is not from better business performance, but from a one-off tax gain.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $566M ▲ | $14.86B ▼ | $8.82B ▼ | $5.96B ▲ |
| Q3-2025 | $489M ▲ | $14.98B ▼ | $9.14B ▼ | $5.77B ▼ |
| Q2-2025 | $423M ▲ | $15.22B ▲ | $9.31B ▲ | $5.83B ▼ |
| Q1-2025 | $418M ▼ | $14.97B ▼ | $9.03B ▼ | $5.87B ▲ |
| Q4-2024 | $837M | $15.21B | $9.36B | $5.78B |
What's financially strong about this company?
EMN has a strong equity base, a long history of profits, and has improved its cash position this quarter. Receivables are down, showing customers are paying faster, and the company is paying suppliers more quickly.
What are the financial risks or weaknesses?
Liquidity is getting tighter as current liabilities rise and current assets shrink. There is a significant amount of goodwill, which could be at risk if acquisitions disappoint, and debt remains moderately high.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $105M ▲ | $502M ▲ | $-47M ▲ | $-382M ▼ | $-489M ▼ | $390M ▲ |
| Q3-2025 | $47M ▼ | $402M ▲ | $-137M ▲ | $-201M ▼ | $66M ▲ | $265M ▲ |
| Q2-2025 | $140M ▼ | $233M ▲ | $-147M ▼ | $-90M ▲ | $5M ▲ | $83M ▲ |
| Q1-2025 | $183M ▼ | $-167M ▼ | $-131M ▲ | $-124M ▲ | $-419M ▼ | $-314M ▼ |
| Q4-2024 | $331M | $540M | $-132M | $-181M | $215M | $365M |
What's strong about this company's cash flow?
The company is generating solid cash from its core business, with operating cash flow and free cash flow both rising sharply from last quarter. Debt is being paid down, and dividends are well covered by cash flow.
What are the cash flow concerns?
Despite strong cash generation, the company ended the quarter with no cash left, which is risky. The boost from working capital changes may not last, and the lack of a cash cushion could be a problem if business slows or unexpected expenses arise.
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Additives And Functional Products | $730.00M ▲ | $770.00M ▲ | $720.00M ▼ | $660.00M ▼ |
Advanced Materials | $720.00M ▲ | $780.00M ▲ | $730.00M ▼ | $660.00M ▼ |
Chemical Intermediates | $550.00M ▲ | $460.00M ▼ | $500.00M ▲ | $420.00M ▼ |
Fibers | $290.00M ▲ | $270.00M ▼ | $250.00M ▼ | $230.00M ▼ |
Revenue by Geography
| Region | Q3-2021 | Q1-2022 | Q2-2022 | Q3-2022 |
|---|---|---|---|---|
Asia Pacific | $660.00M ▲ | $610.00M ▼ | $640.00M ▲ | $660.00M ▲ |
E M E A | $700.00M ▲ | $740.00M ▲ | $680.00M ▼ | $680.00M ▲ |
Latin America | $170.00M ▲ | $160.00M ▼ | $160.00M ▲ | $170.00M ▲ |
North America | $1.20Bn ▲ | $1.20Bn ▲ | $1.30Bn ▲ | $1.20Bn ▼ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Eastman Chemical Company's financial evolution and strategic trajectory over the past five years.
Key strengths include a strong position in specialty chemicals and advanced materials, deep technical and manufacturing know‑how, and a distinctive push into circular and sustainable technologies. The company maintains solid operating cash generation, an improving liquidity profile, and a long history of innovation supported by a sizable patent portfolio and recognized brands. Customer relationships tend to be sticky, and the diversified end‑market exposure spreads risk across multiple industries.
The most prominent risks are the recent deterioration in revenue and profitability, which highlight vulnerability to cyclical demand, pricing pressure, and cost inflation. Leverage remains meaningful, and while liquidity has improved, sustained earnings weakness could eventually strain flexibility. Large‑scale recycling and sustainability projects carry execution, regulatory, and market‑adoption risks. The presence of significant goodwill and intangibles also introduces potential for future write‑downs if acquired or growth businesses underperform expectations.
Looking ahead, the company appears to be in a transition phase: its traditional earnings power has weakened, but its strategic direction toward sustainable and circular materials could support renewed growth if executed well and if customer demand continues to shift in that direction. The balance sheet and cash flows provide some capacity to navigate this period, though not unlimited room for missteps. The medium‑term outlook depends heavily on stabilizing core volumes and margins while successfully scaling its recycling platforms and specialty innovations into durable, higher‑margin revenue streams.
About Eastman Chemical Company
https://www.eastman.comEastman Chemical Company operates as a specialty materials company in the United States and internationally.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $1.97B ▼ | $217M ▼ | $105M ▲ | 5.32% ▲ | $0.92 ▲ | $195M ▼ |
| Q3-2025 | $2.2B ▼ | $223M ▲ | $47M ▼ | 2.13% ▼ | $0.41 ▼ | $319M ▼ |
| Q2-2025 | $2.29B ▼ | $222M ▼ | $140M ▼ | 6.12% ▼ | $1.22 ▼ | $352M ▼ |
| Q1-2025 | $2.29B ▲ | $249M ▲ | $182M ▼ | 7.95% ▼ | $1.58 ▼ | $432M ▼ |
| Q4-2024 | $2.25B | $176M | $330M | 14.7% | $2.85 | $482M |
What's going well?
Net income and EPS jumped this quarter, mainly due to a big tax benefit. R&D spending is steady, and the company remains profitable at the core level.
What's concerning?
Revenue and gross profit both fell sharply, and operating margins are getting squeezed. The improvement in net income is not from better business performance, but from a one-off tax gain.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $566M ▲ | $14.86B ▼ | $8.82B ▼ | $5.96B ▲ |
| Q3-2025 | $489M ▲ | $14.98B ▼ | $9.14B ▼ | $5.77B ▼ |
| Q2-2025 | $423M ▲ | $15.22B ▲ | $9.31B ▲ | $5.83B ▼ |
| Q1-2025 | $418M ▼ | $14.97B ▼ | $9.03B ▼ | $5.87B ▲ |
| Q4-2024 | $837M | $15.21B | $9.36B | $5.78B |
What's financially strong about this company?
EMN has a strong equity base, a long history of profits, and has improved its cash position this quarter. Receivables are down, showing customers are paying faster, and the company is paying suppliers more quickly.
What are the financial risks or weaknesses?
Liquidity is getting tighter as current liabilities rise and current assets shrink. There is a significant amount of goodwill, which could be at risk if acquisitions disappoint, and debt remains moderately high.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $105M ▲ | $502M ▲ | $-47M ▲ | $-382M ▼ | $-489M ▼ | $390M ▲ |
| Q3-2025 | $47M ▼ | $402M ▲ | $-137M ▲ | $-201M ▼ | $66M ▲ | $265M ▲ |
| Q2-2025 | $140M ▼ | $233M ▲ | $-147M ▼ | $-90M ▲ | $5M ▲ | $83M ▲ |
| Q1-2025 | $183M ▼ | $-167M ▼ | $-131M ▲ | $-124M ▲ | $-419M ▼ | $-314M ▼ |
| Q4-2024 | $331M | $540M | $-132M | $-181M | $215M | $365M |
What's strong about this company's cash flow?
The company is generating solid cash from its core business, with operating cash flow and free cash flow both rising sharply from last quarter. Debt is being paid down, and dividends are well covered by cash flow.
What are the cash flow concerns?
Despite strong cash generation, the company ended the quarter with no cash left, which is risky. The boost from working capital changes may not last, and the lack of a cash cushion could be a problem if business slows or unexpected expenses arise.
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Additives And Functional Products | $730.00M ▲ | $770.00M ▲ | $720.00M ▼ | $660.00M ▼ |
Advanced Materials | $720.00M ▲ | $780.00M ▲ | $730.00M ▼ | $660.00M ▼ |
Chemical Intermediates | $550.00M ▲ | $460.00M ▼ | $500.00M ▲ | $420.00M ▼ |
Fibers | $290.00M ▲ | $270.00M ▼ | $250.00M ▼ | $230.00M ▼ |
Revenue by Geography
| Region | Q3-2021 | Q1-2022 | Q2-2022 | Q3-2022 |
|---|---|---|---|---|
Asia Pacific | $660.00M ▲ | $610.00M ▼ | $640.00M ▲ | $660.00M ▲ |
E M E A | $700.00M ▲ | $740.00M ▲ | $680.00M ▼ | $680.00M ▲ |
Latin America | $170.00M ▲ | $160.00M ▼ | $160.00M ▲ | $170.00M ▲ |
North America | $1.20Bn ▲ | $1.20Bn ▲ | $1.30Bn ▲ | $1.20Bn ▼ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Eastman Chemical Company's financial evolution and strategic trajectory over the past five years.
Key strengths include a strong position in specialty chemicals and advanced materials, deep technical and manufacturing know‑how, and a distinctive push into circular and sustainable technologies. The company maintains solid operating cash generation, an improving liquidity profile, and a long history of innovation supported by a sizable patent portfolio and recognized brands. Customer relationships tend to be sticky, and the diversified end‑market exposure spreads risk across multiple industries.
The most prominent risks are the recent deterioration in revenue and profitability, which highlight vulnerability to cyclical demand, pricing pressure, and cost inflation. Leverage remains meaningful, and while liquidity has improved, sustained earnings weakness could eventually strain flexibility. Large‑scale recycling and sustainability projects carry execution, regulatory, and market‑adoption risks. The presence of significant goodwill and intangibles also introduces potential for future write‑downs if acquired or growth businesses underperform expectations.
Looking ahead, the company appears to be in a transition phase: its traditional earnings power has weakened, but its strategic direction toward sustainable and circular materials could support renewed growth if executed well and if customer demand continues to shift in that direction. The balance sheet and cash flows provide some capacity to navigate this period, though not unlimited room for missteps. The medium‑term outlook depends heavily on stabilizing core volumes and margins while successfully scaling its recycling platforms and specialty innovations into durable, higher‑margin revenue streams.

CEO
Mark J. Costa
Compensation Summary
(Year 2024)
Upcoming Earnings
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2011-10-04 | Forward | 2:1 |
ETFs Holding This Stock
Summary
Showing Top 3 of 220
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
Evercore ISI Group
In Line
Citigroup
Buy
B of A Securities
Buy
JP Morgan
Overweight
Deutsche Bank
Hold
RBC Capital
Sector Perform
Grade Summary
Showing Top 6 of 14
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:14.34M
Value:$1.08B
BLACKROCK, INC.
Shares:13.7M
Value:$1.03B
BLACKROCK INC.
Shares:8.42M
Value:$635.55M
Summary
Showing Top 3 of 1,033

